Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CSPC Baike (Yantai) Biopharmaceutical

2010 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer and seller of oncology drugs. The company manufactures and sells of oncology drugs including pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) injection and recombinant human granulocyte colony stimulating factor (rhG-CSF) injection.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
CSPC NBP Pharmaceutical
Primary Office
  • Yantai
  • China

CSPC Baike (Yantai) Biopharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore CSPC Baike (Yantai) Biopharmaceutical‘s full profile, request access.

Request full access to PitchBook

CSPC Baike (Yantai) Biopharmaceutical Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore CSPC Baike (Yantai) Biopharmaceutical‘s full profile, request access.

Request full access to PitchBook